• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.65% Nasdaq Down0.40%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    553.81 Up 0.15(0.03%) 3:52PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.1
    Mean Recommendation (last week):2.1
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:535.04
    Median Target:521.00
    High Target:650.00
    Low Target:450.00
    No. of Brokers:23

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jul 22, 2015Northland CapitalInitiated Market Perform
    Mar 20, 2015Chardan Capital MarketsInitiated Buy
    Feb 19, 2015ROTH CapitalDowngradeBuyNeutral
    Jul 21, 2014ArgusInitiated Buy
    Apr 16, 2014Canaccord GenuityInitiated Buy
    Feb 13, 2014OppenheimerDowngradeOutperformPerform
    Aug 22, 2013OppenheimerInitiated Outperform
    May 17, 2013UBSInitiated Neutral
    Feb 28, 2013BarclaysInitiated Overweight
    Jan 10, 2012Robert W. BairdUpgradeNeutralOutperform

    More Upgrades & Downgrades for REGN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy991010
    Buy5666
    Hold7888
    Underperform1000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.